Stock Events

Stock Events

Scorpius 

$0.02
82
+$0.01+66.67% Thursday 19:40

Statistics

Day High
0.04
Day Low
0.02
52W High
0.16
52W Low
0
Volume
36,122
Avg. Volume
22,842
Mkt Cap
1.22M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27MayExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q4 2025
Next
-32
-5.54
20.91
47.37
Expected EPS
N/A
Actual EPS
N/A

Financials

-525.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
12.49MRevenue
-65.62MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCPX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap10.61B
Moderna is a leader in mRNA technology, directly competing with Nighthawk Biosciences in the development of innovative vaccines and therapies.
BioNTech
BNTX
Mkt Cap24.99B
BioNTech competes in the mRNA space, similar to Nighthawk Biosciences, focusing on personalized immunotherapies and vaccines.
Novavax
NVAX
Mkt Cap1.36B
Novavax is a competitor in the vaccine development space, particularly for infectious diseases, which aligns with Nighthawk Biosciences' focus areas.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company with a broad portfolio that includes vaccines and biopharmaceuticals, competing across several of Nighthawk Biosciences' interest areas.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of vaccines and therapeutics, overlapping with Nighthawk Biosciences' research and development.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is involved in the development of antiviral drugs, directly competing with Nighthawk Biosciences in the area of infectious disease treatment.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals competes in the biotechnology space, focusing on monoclonal antibodies, a technology that could be in direct competition with Nighthawk Biosciences' therapeutic approaches.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals is involved in creating novel therapies for treating serious diseases, potentially competing with Nighthawk Biosciences in the biotech innovation space.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company focused on human therapeutics, competing with Nighthawk Biosciences in the development of treatments for various diseases.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Nighthawk Biosciences in areas such as oncology, cardiovascular, renal & metabolism, and respiratory diseases.

About

Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Show more...
CEO
Mr. Jeffrey Alan Wolf J.D.
Employees
90
Country
US
ISIN
US42237K5083

Listings

OTC Link
US
SCPX

0 Comments

Share your thoughts

FAQ

What is Scorpius stock price today?▼
The current price of SCPX is $0.02 USD — it has increased by +66.67% in the past 24 hours. Watch Scorpius stock price performance more closely on the chart.
What is Scorpius stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Scorpius stocks are traded under the ticker SCPX.
Is Scorpius stock price growing?▼
SCPX stock has risen by +53.85% compared to the previous week, the month change is a +100% rise, over the last year Scorpius has showed a -85.02% decrease.
What is Scorpius market cap?▼
Today Scorpius has the market capitalization of 1.22M
When is the next Scorpius earnings date?▼
Scorpius is going to release the next earnings report on May 27, 2026.
What is Scorpius revenue for the last year?▼
Scorpius revenue for the last year amounts to 12.49M USD.
What is Scorpius net income for the last year?▼
SCPX net income for the last year is -65.62M USD.
How many employees does Scorpius have?▼
As of April 03, 2026, the company has 90 employees.
In which sector is Scorpius located?▼
Scorpius operates in the Health Care sector.
When did Scorpius complete a stock split?▼
The last stock split for Scorpius was on July 18, 2024 with a ratio of 1:200.
Where is Scorpius headquartered?▼
Scorpius is headquartered in San Antonio, US.